Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04531696

UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

UPTIDER is a prospective, interventional, non-Investigational Medicinal Product (non-IMP), non-commercial, single centre post-mortem tissue donation program for metastatic breast cancer patients or patients with a germline pathogenic variant with a moderate to high lifetime risk of breast cancer and at least one malignancy at time of death. The overarching objective of UPTIDER is (i) to unravel metastatic breast cancer evolution, biology, heterogeneity and treatment resistance and (ii) to assess pathogenicity and tumour biology in hereditary cancer syndromes with a high lifetime risk of breast cancer; both through extensive post-mortem multi-level and multi-region sample analysis.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood drawBlood draw at inclusion
PROCEDUREPost-mortem tissue collectionSample collection (both liquids, tumour tissue and non-tumour tissue) during post-mortem research autopsy

Timeline

Start date
2020-11-30
Primary completion
2035-09-01
Completion
2035-09-01
First posted
2020-08-28
Last updated
2024-06-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04531696. Inclusion in this directory is not an endorsement.